Fenbendazole and Ivermectin for Pancreatic Cancer Success Stories: 48 Case Reports (July 2026 Update)

Introduction Pancreatic cancer is among the most aggressive and difficult cancers to treat, particularly in its later stages. Approaches to improve pancreatic cancer therapy are essential as this disease has a very bleak outcome. Approximately 80% of pancreatic cancers are pancreatic ductal adenocarcinomas (PDAC). PDAC is a cancer which is difficult to effectively treat as it is often detected…